Bill Aims To Expand ANDA First Filer Exclusivity

Law360, New York (June 23, 2009, 12:00 AM EDT) -- Sen. Bill Nelson, D-Fla., has introduced legislation in the U.S. Senate to revise the Hatch-Waxman Act's definition of “first applicant” for abbreviated new drug application filers to give generic-drug makers challenging brand-name patents a shot at receiving 180-day market exclusivity.

The Drug Price Competition Act of 2009, introduced Monday, would preserve the 180-day exclusivity period currently granted to the first company to submit a successful ANDA application.

However, if passed, the bill would give companies who successfully litigate past patent roadblocks the opportunity to claim market...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.